Stevanato Group S.p.A., a global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, unveiled two new offerings for small batch pharmaceutical manufacturing: the EZ-fill Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers (TEC).

According to the company, the new EZ-fill Kit offers fast access to a customizable and versatile solution to pharma and biotech companies needing to efficiently fill small batches with high-quality injectable formulations during clinical trials or commercial phases.

Stevanato Group’s EZ-fill Kit builds on its existing ready-to-use platform of pre-sterilized containment solutions—vials, cartridges, and syringes—allowing customers to screen different primary packaging in combination with drug products. The kit will be available as a modular box made up of glass ready-to-use drug containers and add-on components on request, shipped by courier. EZ-fill Kit is expected to be available commercially beginning in the second quarter of 2024.

Additionally, to better support customers, Stevanato Group has introduced a non-GMP laboratory filling and finishing service at its Technology Excellence Centers (TEC) in Boston, MA, and Piombino Dese, Italy. This new service allows customers to assess and identify the possible effects of the fill-and-finish process on their product performance as early as the container selection stage, thus de-risking processes and enhancing development and commercialization strategy.

“In the race to bring new advanced biopharmaceutical products to market and to patients, Stevanato Group is tackling the challenge of supporting customers with flexible drug containment and filling solutions in a timely manner,” said Fabio Bertacchini, senior director EZ-fill vials and cartridges, Stevanato Group. “Stevanato Group remains focused on developing new offerings that can help raise pharmaceutical manufacturing standards. By leveraging the expertise provided by our global TEC Centers, we aim to support customers’ innovation, helping them face tests and de-risking processes and making right-the-first-time choices throughout their drug development journey.”